Supercharge Your Innovation With Domain-Expert AI Agents!

Preparation method of anti-human CD70 nano antibody for blocking combination of CD70 and ligand CD27 thereof and coding sequence of anti-human CD70 nano antibody

A nanobody and sequence technology, applied in the field of medicine and biology, to achieve the effects of small molecular weight, large storage capacity, shortening time and cost

Pending Publication Date: 2022-04-01
新疆优迈生物技术有限公司
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] At present, there are no reports and clinical applications of nanobodies against CD70 targets, so there is an urgent need in this field to develop new specific nanobodies that are effective against CD70 targets

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of anti-human CD70 nano antibody for blocking combination of CD70 and ligand CD27 thereof and coding sequence of anti-human CD70 nano antibody
  • Preparation method of anti-human CD70 nano antibody for blocking combination of CD70 and ligand CD27 thereof and coding sequence of anti-human CD70 nano antibody
  • Preparation method of anti-human CD70 nano antibody for blocking combination of CD70 and ligand CD27 thereof and coding sequence of anti-human CD70 nano antibody

Examples

Experimental program
Comparison scheme
Effect test

Embodiment example 1

[0053] Example 1: Construction of a single domain heavy chain antibody immune library targeting human CD70:

[0054] (1) Xinjiang Bactrian camels were immunized with eukaryotic human CD70 protein once every two weeks for a total of six consecutive immunizations. (2) After the six immunizations, the serum titer was detected by indirect ELISA. Lymphocytes in camel peripheral blood were isolated and total RNA was extracted (TRIZOL method). (3) According to TAKARA's Primescript Tm RT reagent kit with gDNA Eraser reagent instructions will extract the total RNA, such as figure 1 shown. Then reverse transcribe the RNA into cDNA, and then use the PCR method to amplify the VHH chain, including two rounds of PCR, the first round of PCR:

[0055] Upstream primer CALL01-Leader: 5'-GTCCTGGCTGCTCTTCTACAAGG-3'

[0056] Downstream primer CALL02-CH2: 5'-GGTACGTGCTGTTGAACTGTTCC-3'

[0057] The first round of PCR reaction conditions: pre-denaturation at 95°C for 5min, 95°C for 10s, 56°C fo...

Embodiment example 2

[0064] Example 2: Screening of anti-CD70 nanobody, identification and sequencing of positive clones

[0065] 1. Large-capacity CD70 phage nanobody library amplification

[0066] Inoculate the library in 100 mL of SB liquid medium (containing 10% glucose, 100 μg / mL ampicillin) to OD600 of 0.1, culture at 37 °C and 200 r / min until OD600 reaches 0.5, and add helper phage according to the multiplicity of infection 20:1 M13K07, 37°C, after static infection for 30 minutes, culture at 37°C, 100r / min for 30 minutes. Centrifuge the culture, resuspend the pellet with 50 mL of SB (containing 100 μg / mL ampicillin and 50 μg / mL kanamycin), cultivate overnight at 30°C, 220 r / min, and centrifuge at 4°C, 8000rpm Add 5×PEG / NaCl solution and place on ice for 2h, centrifuge at 12000rpm for 30min, resuspend the pellet in phosphate buffer (PBS, 0.01 M, pH 7.4), and obtain the anti-CD70 single domain heavy chain antibody immune library , Take 10 μL to measure the titer of the amplified library.

...

Embodiment example 3

[0096] Example 3: Expression and purification of CD70 nanobody

[0097] 1. Expression of CD70 nanobody

[0098] In this patent, the two positive clones identified by sequencing were not subcloned into other expression vectors, but the original vector pMECS and the original host strain TG1 were used for protein expression, and the clone was named TG1-pMECS-VHH. Streak the original strain on the SB-AG solid medium plate, put it upright for 10 minutes, and culture it upside down overnight. On the second day, single clones on the solid plate were picked and placed in 10 mL of SB-AG liquid medium containing 100 ug / mL ampicillin antibiotic, and cultured with shaking at 220 rpm at 37°C for 8 hours as bacterial seed liquid.

[0099] Inoculate the bacterial seed solution at 1% into SB-A liquid medium, culture at 37°C with shaking at 220rpm to OD600=0.8, add IPTG to a final concentration of 1mM, and cultivate overnight at 30°C at 150rpm. The next day, the supernatant was discarded by ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an anti-human CD70 nano antibody and a VHH chain thereof, the anti-human CD70 nano antibody comprises a framework region FR and a complementarity determining region CDR, the framework region is selected from amino acid sequences of FR1-FR4, and the CDR region is selected from amino acid sequences of CDR1-CDR3. The invention also discloses a gene sequence for coding the nano antibody and a host cell for expressing the nano antibody. The CD70 nano antibody is small in molecular weight and strong in specificity, and has relatively obvious specificity of blocking CD70-CD27 binding. The nano antibody can be used for soluble expression of protein in escherichia coli, the preparation method is simple, the cost is low, and the nano antibody has a good application prospect in detection of human CD70 and antitumor drugs.

Description

technical field [0001] The invention relates to the field of medicine and biology, and discloses a single-domain antibody against CD70 and its derivative protein. Specifically, the present invention discloses a preparation method of an anti-human CD70 nanobody that blocks the binding of CD70 and CD27, its coding sequence and its use, especially in the treatment and / or prevention, or diagnosis of CD70-related diseases such as tumors. use. Background technique [0002] In recent years, the development of new cancer therapeutics has focused on molecular targets, especially proteins associated with cancer progression. The list of molecular targets associated with tumor growth, invasion, and metastasis continues to expand to include proteins overexpressed by tumor cells as well as targets associated with systems that support tumor growth, such as the vasculature and the immune system. The number of therapeutic or anticancer drugs designed to interact with these molecular target...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K16/28C12N15/13A61K47/68A61K39/395A61P35/00A61P19/02A61P29/00A61P37/02A61P17/06G01N33/574G01N33/68
Inventor 李江伟
Owner 新疆优迈生物技术有限公司
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More